In summary, the inhibition of mitochondrial biogenesis by HIF depends mainly on the regulation of key genes, such as c-Myc, PGC-1, and PINK1, which may also provide new therapeutic targets for future cancer treatment. The gene discussed is MYC; the disease is cancer.